Rentokil Initial

14/02/26 -"Terminix turnaround on track"

PDF page sample
Pages
45
Language
English
Published on
14/02/26
Download
You may also be interested by these reports :
19/02/26
The reduction of the target price is derived from the downward revision of our EPS expectations and DCF valuation (see the respective comments). The ...
17/02/26
DKSH’s FY25 result has been well received, with the share price rising ~7% on strong core EBIT growth. Sales and EBIT growth at CER exceeded ...
14/02/26
Terminix turnaround on track
11/02/26
SGS’ 2025 results met expectations on sales, including organic growth, and were ahead on profits. The beat on profits resulted from the successful ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO